UC San Diego engineers have developed an experimental vaccine that could prevent the spread of metastatic cancers to the lungs. Its success lies in targeting a protein known to play a central role in cancer growth and spread, rather than targeting the primary tumor itself.
The United States’ respiratory virus season — which typically lasts from October to April — is making its annual return. The flu, COVID-19, respiratory syncytial virus (RSV) infection and other respiratory illnesses tend to circulate more in the fall and winter months, which can lead to a surge in hospitalizations.
A brief filed on behalf of 111 public health and health law and policy Deans and Scholars, the American Public Health Association, the Robert Wood Johnson Foundation, Trust for America’s Health, and ChangeLab Solutions highlights new findings on the preventive health gains at stake in Braidwood Management v Becerra.
CastleVax, a clinical stage vaccine platform company, has received a Project NexGen award valued at up to $338 million from the Biomedical Advanced Research and Development Authority (BARDA), to support the development of a next-generation, booster vaccine to protect against COVID-19 for years to come.
A UNLV-led team studied potentially fatal, diarrhea-causing Shigella bacteria, and demonstrated a possible way to prevent it from causing disease.
Dendritic cells are key orchestrators of the immune response, but most vaccination strategies don’t effectively target them. NIBIB-funded researchers have developed biodegradable nanoparticles that are designed to deliver mRNA cargo to dendritic cells in the spleen.
A guide to vaccines that adults - especially older adults and those with underlying health issues - should get to avoid serious illness this fall and winter, and beyond.
Hackensack Meridian Jersey Shore University Medical Center’s new four-year Anesthesiology Residency Program, launching spring 2024, recently earned accreditation from the Accreditation Council for Graduate Medical Education (ACGME).
A research group from Japan has developed a method to produce highly active mRNA vaccines at high purity using a unique cap to easily separate the desired capped mRNA.
EVEscape predicts future viral mutations, new variants using evolutionary, biological information
On Friday October 6th, the Centers for Medicare & Medicaid Services (CMS) announced new guidance in response to the August ruling in Texas Medical Association v. United States Department of Health and Human Services (“TMA III”) that vacated several provisions of the existing No Surprises Act (NSA) regulations.
A person’s immune response to variants of SARS-CoV-2, the virus that causes COVID-19, depends on their previous exposure – and differences in the focus of immune responses will help scientists understand how to optimise vaccines in the future to provide broad protection.
As Streptococcus A cases continue to be prevalent in Queensland and internationally, a new nasal vaccine could provide long-term protection from the deadly bacteria.
The Johns Hopkins Bloomberg School of Public Health is hosting an expert briefing for the media from 2:00 p.m. to 2:30 p.m. EDT, Thursday, October 12, on how to take steps to stay healthy as COVID and RSV cases climb and flu season approaches.
The new COVID-19 EG.5 variant is responsible for around 22% of current cases. The World Health Organization has classified it as a “variant of interest,” meaning countries should monitor it more closely than other strains — and cases have only increased in the past few weeks. Peter Gulick is an expert on infectious diseases, and he provides insight on what this new variant could mean and what you should know.
Cases of COVID-19 are up since this summer, and a new vaccine is available. A Penn State Health infectious disease expert offers the latest on the pandemic.
If it’s autumn, then it must be influenza season, which means it’s time to consider flu shots for your family.
A biochemist who got her start at the Uniformed Services University (USU), Dr. Katalin Karikó, was awarded the Nobel Prize in Medicine on Oct. 2 for her key discoveries that led to the development of the mRNA vaccines against COVID-19.
HPV, or human papillomavirus, is the most common sexually transmitted infection. It is also the leading cause of cervical cancer. Over 1,400 Canadian women are affected yearly, with almost 400 deaths, according to the Canadian Cancer Society.
University of Maryland School of Medicine (UMSOM) researchers, as part of the Infectious Diseases Clinical Research Consortium (IDCRC), provided an interim analysis showing that the pentavalent (NmCV-5) meningitis vaccine is safe for use in 9-month-old infants in the meningitis belt of sub-Saharan Africa.
Altered measles and mumps viruses could be used as a platform to create a trivalent COVID-19 vaccine that triggers immunity to multiple variant strains of the SARS-CoV-2 virus, new research in animals suggests.
The American Physiological Society (APS) extends congratulations to Katalin Karikó, PhD, and Drew Weissman, MD, PhD, the 2023 recipients of the Nobel Prize in Physiology or Medicine.
Researchers from the University of Pittsburgh and the National Institutes of Health (NIH) Vaccine Research Center have developed an improved way to test potential vaccines against bird flu. The report was published this week in the journal iScience.
PHILADELPHIA – The University of Pennsylvania messenger RNA pioneers whose years of scientific partnership unlocked understanding of how to modify mRNA to make it an effective therapeutic—enabling a platform used to rapidly develop lifesaving vaccines amid the global COVID-19 pandemic—have been named winners of the 2023 Nobel Prize in Physiology or Medicine.
A single-dose therapy has been developed that is highly effective against lyssavirus infection (rabies), one of the deadliest known viral infections of humans.
Below are some of the latest headlines in the Women's Health channel on Newswise.
Research conducted at Mount Sinai and Yale confirms long COVID is a biological disease by showing blood biomarkers that can predict who has it
This World Lung Day, Sept. 25, the Forum of International Respiratory Societies (FIRS) and its founding member the American Thoracic Society, is calling on governments and health care providers worldwide to give equitable access to preventative services and treatments for respiratory conditions, and lifesaving pneumonia vaccines for children.
A Rutgers infectious disease expert explains what you need to know about this year’s flu, COVID and new RSV shots
A study has revealed new details about a key population of immune system cells critical to successful vaccination against the pandemic virus, SARS-CoV-2.
A Ludwig Cancer Research study has shown that combining adoptive T cell therapy (ACT) with an innovative, personalized cancer vaccine under development at the Lausanne Branch of the Ludwig Institute for Cancer Research can benefit patients with late-stage, drug-resistant ovarian cancer.
In a study published online in CELL today, scientists at UCSF QBI, University College London and the Icahn School of Medicine at Mount Sinai reported breakthrough findings on convergent evolutionary mechanisms shared by COVID-19 variants, allowing them to overcome both adaptive and innate immune system barriers.
Stay ahead of the curve at ANESTHESIOLOGY 2023 (Oct. 13-17) where the most recent advancements and innovations in anesthesia care and pain management will be unveiled.
Researchers will need fewer mice to study lung infections thanks to improvements in dosing methods, according to a new study from the University of California San Francisco (UCSF).
As cities brace for a confluence of flu, COVID-19, pneumonia, and RSV infections this fall, the American Thoracic Society announced that five new health systems have partnered with the Society to improve vaccination rates.
University of Delaware researchers conducted exhaustive studies of human papillomavirus (HPV), the most common sexually transmitted infection (STI) in the world. They confirmed 25 different types of HPV prevalent in Nigeria, a discovery that underscores the need for more region-specific vaccines.
The US CDC (Centers for Disease Control and Prevention) funded Global COVID Vaccine Safety Project has generated background incidence rates on a range of conditions designated as AESI (Adverse Events of Special Interest) for COVID-19 vaccine safety monitoring. Conditions studied included myocarditis, pulmonary embolism, and Guillain-Barré syndrome.
One promising approach to treating Type 1 diabetes is implanting pancreatic islet cells that can produce insulin when needed, which can free patients from giving themselves frequent insulin injections.
The American Society of Anesthesiologists (ASA) will testify tomorrow before the House Veterans’ Affairs Subcommittee on Health Oversight and urge Congress to block a U.S. Department of Veterans Affairs (VA) Office of Nursing Services’ proposal to remove physician anesthesiologists from the surgical care of Veterans.
In a new study, researchers analyze the world’s largest social media platform and its efforts to remove Covid-19 vaccine misinformation during the pandemic.
The outbreak of the COVID pandemic in 2020 has once again shown how important reliable and rapid detection methods are to initiate effective measures to combat a pandemic.
A late summer increase in COVID-19-related hospitalizations and the emergence of new coronavirus variants raises concerns about how best to counter infection and who should receive the newly-approved vaccines.
$13 million will fund a multidisciplinary, multi-institution team effort to develop stronger and more versatile vaccines
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
